Efficacy and Safety of TACE-HAIC Combined with Molecular Targeted Therapy and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma · 2026-05 · Volume 13 · 1-12
DOI: 10.2147/jhc.s588860 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-05. Verfasst von Zhipeng Feng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Vascular Interventional Therapy, Clinical Oncology School of Fujian Medical University, Fujan Cancer Hospital, NHC Key Lab…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology and Vascular Interventional Therapy, Clinical Oncology School of Fujian Medical University, Fujan Cancer Hospital, NHC Key Laboratory of Cancer Metabolism, Fuzhou, 350001, People's Republic of Chi…
- Department of Interventional Medicine, Beijing Anzhen Nanchong Hospital, Capital Medical University & Nanchong Central Hospital, Nanchong, 637000, People's Republic of China.
- Department of Vascular and Oncology Intervention, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, 350001, People's Rep…
ORCID-Profile: Zhipeng Feng, Xiaolong Wang, Shiguang Chen, Mingzhi Hao, Wenchang Yu
Zitieren
APA
Feng, Z., Wang, X., Xu, J., Chen, S., Hao, M., Hu, H., Qiu, S., Liao, Y., Yu, W., & Fang, Z. (2026). Efficacy and Safety of TACE-HAIC Combined with Molecular Targeted Therapy and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma, Volume 13, 1-12. https://doi.org/10.2147/jhc.s588860
Vancouver
Feng Z, Wang X, Xu J, Chen S, Hao M, Hu H, et al. Efficacy and Safety of TACE-HAIC Combined with Molecular Targeted Therapy and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-12. doi:10.2147/jhc.s588860
BibTeX
@article{Feng2026,
author = {Feng, Zhipeng and Wang, Xiaolong and Xu, Junming and Chen, Shiguang and Hao, Mingzhi and Hu, Hong and Qiu, Shixiang and Liao, Yunguo and Yu, Wenchang and Fang, Zhuting},
title = {Efficacy and Safety of TACE-HAIC Combined with Molecular Targeted Therapy and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma},
journal = {Journal of Hepatocellular Carcinoma},
year = {2026},
volume = {Volume 13},
pages = {1--12},
doi = {10.2147/jhc.s588860}
}
EUVIMED